Hong Kong's stock market experienced a decrease of 64 points, equivalent to a 0.2% decline, reaching 26,587 on Tuesday morning. This downturn countered the previous day's gains, primarily due to declines in consumer stocks. Investors exhibited caution in anticipation of significant Chinese economic data to be released later in the week, encompassing October's credit growth, industrial production, and retail sales figures. Additionally, market sentiment was further dampened by uncertainty surrounding the outcome of a U.S. Senate vote aimed at concluding the unprecedented 41-day government shutdown, with the voting process still in progress. Nevertheless, the losses were not extensive, as strong performance in Chinese equities provided some support. Chinese stocks had reached a ten-year peak on Monday, buoyed by positive data over the weekend indicating a reduction in producer price deflation and a return to positive consumer price figures for the first time in eight months. Early losses in Hong Kong were led by pharmaceutical stocks, with Hansoh Pharma falling by 2.7%, Wuxi Biologics declining by 1.9%, and Sino Biopharma down by 1.6%.